Stay updated on Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.

Latest updates to the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page
- Check5 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the previous full content and navigation with a minimal header. Users can no longer view the study details and related links on this page.SummaryDifference17%

- Check12 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0 on the study page, representing a minor update to the record without altering study content. This reflects a backend update to the page rather than a change to participant information.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision was updated to v3.6.6, reflecting a CMS/software maintenance update rather than a change to study data or visible content.SummaryDifference0.0%

- Check33 days agoChange DetectedA new entry '2017 ( U.S. NIH Grant/Contract )' was added to the Study ID Numbers, recording an additional funding attribution for the trial.SummaryDifference0.0%

- Check47 days agoChange DetectedA new revision label v3.6.5 was added, replacing the previous v3.6.4.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page's underlying version rather than changes to study details.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Epacadostat vs Standard of Care Clinical Trial page.